SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: June 3, 2004
Date of earliest event reported: June 3, 2004
Maxygen, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State of Incorporation)
000-28401 | 77-0449487 | |
(Commission File No.) | (I.R.S. Employer Identification No.) |
515 GALVESTON DRIVE
REDWOOD CITY, CA 94063
(Address of principal executive offices, including zip code)
(650) 298-5300
(Registrant’s telephone number, including area code)
Item 5. Other Events.
On June 3, 2004, Maxygen, Inc. (the “Company”) and E.I. du Pont de Nemours and Company (“DuPont”) jointly announced that DuPont has signed definitive agreements to acquire Verdia, Inc. (“Verdia”), a wholly-owned subsidiary of the Company. Subject to regulatory approvals and other customary closing conditions, DuPont will purchase Verdia for $64 million in cash. The press release is attached as an exhibit to this Current Report on Form 8-K and is incorporated herein by reference.
Item 7. Financial Statements and Exhibits.
(c) | Exhibits |
99.1 | Joint Press Release, dated June 3, 2004, of Maxygen and DuPont |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MAXYGEN, INC. | ||||
Date: June 3, 2004 | By: | /s/ Michael Rabson | ||
Michael Rabson | ||||
Senior Vice President |